Orchid Cellmark Inc. Company Profile - Sep 08, 2011 by WrightReports


More Info
									Company Fundamentals\Company Profile

   A Wright Investors' Service Research Report:

   Orchid Cellmark Inc.
                                                                                           440 Wheelers Farms Road
                                                                                           Milford, CT 06461 U.S.A.

  Figures in U.S. Dollars

                                  Wright Quality Rating:DBNN                                    Key Data

   Orchid Cellmark Inc. is engaged in the provision of deoxyribonucleic acid (DNA)              Ticker:
   testing services that generate genetic profile information by analyzing an organism's        ORCH
   genetic identity. It also provides non-DNA forensic laboratory services. The
   Company's business is primarily focused on DNA testing for human identity. It                2010 Sales:
   provides DNA testing services for forensic, family relationship and, to a lesser extent,
   security applications. The Company also provides DNA testing services for
   agricultural applications, primarily in selective trait breeding. It provides agricultural
   susceptibility testing to enable farmers to breed sheep resistant to scrapie, a fatal,       Major Industry:
   degenerative disease that affects the nervous systems of sheep and goats. The                Miscellaneous
   Company also provides genetic marker analysis in animals that can be used to
   confirm relationships. It provides DNA testing services to various government                Sub Industry:
   agencies, private individuals and commercial companies.                                      Medical Services
                        Stock Chart                                   Officers
                                                                     Chairman                   Country:
                                                                   Eugene I. Davis              United States

                                                           President & Chief Executive          Currency:
                                                                Thomas A. Bologna
                                                                                                U.S. Dollars

                                                               Vice President & Chief
                                                                                                Fiscal Year Ends:
                                                                  Financial Officer
                                                                   James F. Smith               December



To top